'US FDA observation on some pharma cos are shocking'
| Apr 07, 2016, 11:43:42 AM
Share
Sridhar Sivaram, Investment director of Enam Holdings spoke to ET Now and said that they are seeing signs of pick-up in infra and housing sectors. He also added that the US FDA observation on some pharma companies are shocking.